NCT01080768View on ClinicalTrials.gov

Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

PHASE2TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
HypertensionAnkle Edema
Interventions
DRUG

Aliskiren/amlodipine

Aliskiren/amlodipine 150/5 mg/day

DRUG

Amlodipine

Amlodipine 5 mg/day.

DRUG

Placebo to Aliskiren/amlodipine

Placebo to Aliskiren/amlodipine 150/10 mg/day

DRUG

Placebo to Amlodipine

Placebo to Amlodipine 5 mg/day

Trial Locations (9)

Unknown

Novartis Investigative Site, Beek en Donk

Novartis Investigative Site, Bosch

Novartis Investigative Site, Hoogwoud

Novartis Investigative Site, Lichtenvoorde

Novartis Investigative Site, Lieshout

Novartis Investigative Site, Poortvliet

Novartis Investigative Site, The Hague

Novartis Investigative Site, Utrecht

Novartis Investigative Site, Wildervank

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01080768 - Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension | Biotech Hunter | Biotech Hunter